Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0111-04

DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner...

Anika Therapeutics, Inc. / initiated 2003-10-08 / Terminated

Anika Therapeutics began a recall of DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner; P012-180A Manufactured for Bausch & Lomb on . The reason FDA records is "Stability failure at the 20 month for viscosity specification". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0111-04
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Anika Therapeutics, Inc.
Product
DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner; P012-180A Manufactured for Bausch & Lomb
Product code
LZP Aid, Surgical, Viscoelastic
Reason for recall
Stability failure at the 20 month for viscosity specification
FDA root cause
Other
Action
Anika Therapeutics issued notification on 10/8/2003 by fax and FedEx to three Distributors. Distributors were requested to subrecall to their customers.
Quantity in commerce
4948 units
Distribution
CA, MO, NC,VA
Product codes and lots
Lot Numbers: B020122A, B020122J